Charles Schwab Investment Management Inc Immuneering Corp Transaction History
Charles Schwab Investment Management Inc
- $601 Billion
- Q3 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Immuneering Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 22,344 shares of IMRX stock, worth $143,001. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,344
Previous 12,000
86.2%
Holding current value
$143,001
Previous $40,000
265.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IMRX
# of Institutions
69Shares Held
14.5MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA2.42MShares$15.5 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.8MShares$11.5 Million0.0% of portfolio
-
Exodus Point Capital Management, LP New York, NY1.52MShares$9.71 Million0.11% of portfolio
-
Logos Global Management LP San Francisco, CA950KShares$6.08 Million0.72% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il943KShares$6.04 Million0.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $169M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...